Key F Inancial Inc Viatris Inc Transaction History

Key F Inancial Inc

$433 Million
Q4 2024

A detailed history of Key F Inancial Inc transactions in Viatris Inc stock. As of the latest transaction made, Key F Inancial Inc holds 6,700 shares of VTRS stock, worth $63,650. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,700

Previous 6,836 1.99%

Holding current value

$63,650

Previous $79,000 5.06%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$11.32 - $13.37 $1,539 - $1,818	-136 Reduced 1.99%	6,700 $83,000
Q3 2024 Oct 29, 2024	SELL	$10.32 - $12.13 $15,160 - $17,818	-1,469 Reduced 17.69%	6,836 $79,000
Q2 2024 Jul 29, 2024	SELL	$10.05 - $12.02 $522 - $625	-52 Reduced 0.62%	8,305 $88,000
Q3 2023 Nov 01, 2023	SELL	$9.59 - $11.35 $719 - $851	-75 Reduced 0.89%	8,357 $82,000
Q1 2023 May 02, 2023	SELL	$9.2 - $12.26 $2,511 - $3,346	-273 Reduced 3.14%	8,432 $81,000
Q3 2022 Oct 28, 2022	BUY	$8.48 - $11.13 $38,796 - $50,919	4,575 Added 110.77%	8,705 $74,000
Q2 2022 Jul 26, 2022	SELL	$9.95 - $12.27 $5,810 - $7,165	-584 Reduced 12.39%	4,130 $44,000
Q1 2022 Apr 27, 2022	BUY	$9.81 - $15.4 $6,886 - $10,810	702 Added 17.5%	4,714 $51,000
Q4 2021 Jan 19, 2022	BUY	$12.09 - $14.68 $145 - $176	12 Added 0.3%	4,012 $54,000
Q3 2021 Nov 01, 2021	SELL	$13.25 - $15.13 $2,809 - $3,207	-212 Reduced 5.03%	4,000 $54,000
Q2 2021 Aug 02, 2021	SELL	$12.97 - $16.15 $7,094 - $8,834	-547 Reduced 11.49%	4,212 $59,000
Q1 2021 Apr 30, 2021	BUY	$13.59 - $18.54 $9,676 - $13,200	712 Added 17.59%	4,759 $66,000
Q4 2020 Jan 29, 2021	BUY	$14.3 - $18.74 $57,872 - $75,840	4,047 New	4,047 $76,000

Others Institutions Holding VTRS

# of Institutions

1,141

Shares Held

988M

Call Options Held

2.34M

Put Options Held

2.21M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.5B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.

Account

Key F Inancial Inc Viatris Inc Transaction History